Please join us for an exclusive webinar with Vesiflo, a pioneering company dedicated to revolutionizing urinary catheters. Headed by a senior industry veteran, Vesiflo’s mission is to reinvent urinary catheters. Their first product, the inFlow™ voiding prosthesis, provides women with neurologically-impaired bladder function their first alternative to lifelong catheter use. The inFlow™ uses advanced technology to restore function and dignity. With FDA approval and anticipated Medicare reimbursement starting January 1, 2025, the inFlow™ is poised for substantial growth in the U.S. market, which has an estimated TAM of $1.5 billion per year.
Key highlights:
- Future Pipeline
- Practice-Changing Technology
- Large Market Opportunity
- Competitive Edge
- Regulatory Approval
- Medicare Reimbursement
- High Profitability
- Pent-Up Demand
- Experienced Leadership
If you have trouble registering please email Connect@SFOGevents.com.